Mesa Laboratories, Inc.

MLAB

US59064R1095

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 26/06/2024 BST			5-day change	1st Jan Change
88.18 ^USD	-1.96%		-3.40%	-15.83%

06-05	Earnings Flash (MLAB) MESA LABORATORIES Posts Q4 Revenue $58.9M, vs. Street Est of $55.3M	MT
06-05	Earnings Flash (MLAB) MESA LABORATORIES Posts Q4 EPS $2.77, vs. Street Est of $1.75	MT

Mesa Laboratories, Inc. Reports Impairment of Goodwill and Long-Lived Assets for the Fourth Quarter Ended March 31, 2024

June 05, 2024 at 11:04 am

Mesa Laboratories, Inc. reported Impairment of goodwill and long-lived assets for the fourth quarter ended March 31, 2024 of $274,533,000.

Latest news about Mesa Laboratories, Inc.

Earnings Flash (MLAB) MESA LABORATORIES Posts Q4 Revenue $58.9M, vs. Street Est of $55.3M	06-05	MT
Earnings Flash (MLAB) MESA LABORATORIES Posts Q4 EPS $2.77, vs. Street Est of $1.75	06-05	MT
Mesa Laboratories, Inc. Reports Impairment of Goodwill and Long-Lived Assets for the Fourth Quarter Ended March 31, 2024	06-05	CI
Mesa Laboratories, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	06-05	CI
Mesa Laboratories, Inc. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	06-05	CI
Mesa Laboratories, Inc. Delays Earnings Announcement for the Fourth Quarter and Full Fiscal Year 2024 Results	05-22	CI
Mesa Laboratories, Inc. Amends and Restates Its Senior Secured Credit Agreement with Syndicate of Banks Led by JPMorgan Chase Bank, N.A	04-08	CI
Mesa Laboratories, Inc. Declares Regular Quarterly Dividend, Payable on June 14, 2024	04-04	CI
Mesa Laboratories, Inc. announced that it expects to receive $71.25 million in funding	04-04	CI
Mesa Laboratories, Inc. Provides Impairment Guidance for the Fourth Quarter of 2024	04-02	CI
Earnings Flash (MLAB) MESA LABORATORIES Posts Q3 Revenue $53.5M	02-05	MT
Earnings Flash (MLAB) MESA LABORATORIES Reports Q3 EPS $2.02	02-05	MT
Mesa Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-05	CI
Mesa Laboratories, Inc. Appoints Mark Capone to Its Board of Directors	01-08	CI
Mesa Laboratories Maintains Quarterly Dividend at $0.16 a Share, Payable March 15 to Shareholders of Record as of Feb. 29	01-04	MT
Mesa Laboratories, Inc. Declares Regular Quarterly Dividend, Payable on March 15, 2024	01-04	CI
Evercore ISI Upgrades Mesa Laboratories to Outperform From In-Line, Raises Price Target to $125 From $100	01-04	MT
Mesa Laboratories Completes Acquisition of GKE's Chinese Sales Entity	01-03	MT
Mesa Laboratories, Inc. acquired Beijing GKE Science & Technology Co. LTD for ?5 million	12-30	CI
Earnings Flash (MLAB) MESA LABORATORIES Posts Q2 Revenue $53.2M	11-06	MT
Earnings Flash (MLAB) MESA LABORATORIES Posts Q2 EPS $1.91	11-06	MT
Tranche Update on Mesa Laboratories, Inc.'s Equity Buyback Plan announced on November 10, 2005.	11-06	CI
Mesa Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-06	CI
Mesa Laboratories Completes Acquisition of GKE's Sterilization Indicators Business, Testing Lab SAL	16/10/23	MT
Mesa Laboratories, Inc. entered into a definitive agreement to acquire Beijing GKE Science & Technology Co. LTD for ?5 million.	15/10/23	CI

Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.

Sector

Medical Equipment, Supplies & Distribution

Calendar

31/07/2024 - Q1 2025 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Mesa Laboratories, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

88.18 USD

Average target price

125 USD

Spread / Average Target

+41.76%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
MESA LABORATORIES, INC.	-15.83%	476M
ABBOTT LABORATORIES	-4.72%	182B
MEDTRONIC PLC	-2.83%	103B
BECTON, DICKINSON AND COMPANY	-5.01%	66.94B
CENCORA, INC.	+15.53%	46.73B
DEXCOM, INC.	-8.53%	45.14B
HOYA CORPORATION	+5.82%	41.57B
METTLER-TOLEDO INTERNATIONAL, INC.	+17.67%	30.48B
TERUMO CORPORATION	+14.00%	24.26B
WEST PHARMACEUTICAL SERVICES, INC.	-8.08%	23.58B

Other Medical Equipment, Supplies & Distribution